Loading clinical trials...
Loading clinical trials...
Prospective Randomized Open-label Trial of Atorvastatin as Adjunctive Treatment of COVID-19
Conditions
Interventions
Atorvastatin
Locations
1
United States
Mount Auburn Hospital
Cambridge, Massachusetts, United States
Start Date
June 25, 2020
Primary Completion Date
December 31, 2021
Completion Date
May 8, 2022
Last Updated
March 19, 2021
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
Mount Auburn Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions